Received Sep 4, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | UNK | — | — |
immune-type problems after COVID vaccination; skin blotted; This spontaneous case was reported by a consumer and describes the occurrence of IMMUNE SYSTEM DISORDER (immune-type problems after COVID vaccination) and RASH MACULAR (skin blotted) in an adult female patient who received SPIKEVAX NOS (SPIKEVAX NOS) for COVID-19 prophylaxis. On an unknown date, the patient received dose of SPIKEVAX NOS (SPIKEVAX NOS) (unknown route) 1 dosage form. On an unknown date, the patient experienced IMMUNE SYSTEM DISORDER (immune-type problems after COVID vaccination) and RASH MACULAR (skin blotted). The patient was treated with Prednisone at an unspecified dose and frequency. At the time of the report, IMMUNE SYSTEM DISORDER (immune-type problems after COVID vaccination) and RASH MACULAR (skin blotted) outcome was unknown. The action taken with SPIKEVAX NOS (SPIKEVAX NOS) (Unknown) was unknown. No concomitant medication was reported. Medical History (vaccines within the past 4 weeks, medical conditions) was reported unknown. The patient had immune-type problems after COVID vaccination. She showed pictures of her skin blotted and to be on prednisone. It was unknown if the patient experienced any additional symptoms/events. This case created for 1 female patient out of 3 female patients. This case was linked to US-MODERNATX, INC.-MOD-2025-788968 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2025-788968:Patient 1 of 3